Company Increases 2011 Total Revenue 91% versus 2010

Company Schedules Shareholder Conference Call for May 21

BETHLEHEM, PA., May 15, 2012 /PRNewswire-FirstCall/ — MedClean Technologies, Inc. (OTC Bulletin Board: MCLN) today announced financial results for the 12-month period ended December 31, 2011.

2011 Year-end Operational Highlights:

·       Total revenue for 2011 increased 91% to $1,717,721 compared to $896,993 for 2010. 

·       Gross profit for 2011 increased 54% to $725,752 compared with gross profit of $470,295 for 2010.

·       Net cash used in operating activities decreased to $1,1067,913 in 2011 from $1,882,435 in 2010.

2011 Fourth Quarter Operational Highlights:

·       Fourth quarter revenue, including system sales of $115,000 in the quarter, was $330,594.

·       Maintenance Revenue of $59,423 held close to the quarterly projected amount of $62,000.

·       Corrective Maintenance of $103,444 exceeded the quarterly projected amount of $74,000 and compares to $93,820 in the fourth quarter of 2010.

·       MedClean’s new ecommerce line of business (MedClean GPO), which was launched in the third quarter 2011, generated $42,205 for the full year 2011 and the acceleration initially expected during the first half of 2012 is now expected to start in the third quarter due to delays in launching new products. The Company continues to plan on introducing other mainstream consumable products such as red bags, autoclave bags boxes during 2012

·       Consumables for MedClean Systems (cart liners, deodorizer, supplies, etc.,) generated revenue of $28,963 in the fourth quarter, below the Company’s targeted run rate of $34,500 per quarter.  Fluctuations are expected to occur quarterly in the future based upon customer needs.

“Year-over-year revenue results were extremely positive and we managed to continue to reduce our operational expenses while growing our revenue,” stated David Laky, President & CEO of MedClean Technologies, Inc. “Our overall business plan has been well received by partners and peers in the market.  The Company will continue to focus on building operational integrity through improving recurring revenue streams, implementing the localized processing center model, and managing operating expenses. We have also begun the process of investigating new business opportunities through tighter integration with partners and providers of industry related products and services that would benefit from our industry expertise and connectivity developed via our distributor and IMWTA hauler network. While I commend our team for the hard work and strong improvements in 2011, we all understand that we have to compound these improvements to scale our business model with the first goal of profitability while also expanding our addressable market with the new opportunities outside of one-time system sales. 

Mr. Laky added, “We will be hosting a conference call with investors on Monday, May 21, 2012 at 1:30 p.m. The call will include an overview of our 2011 financial results and will include a question and answer session for shareholders.  We feel this type of communication will provide the best forum to provide additional information on recent developments.”

Full Year Financial Results:

Total revenue for 2011 was $1,717,721 compared with $896,993 for 2010, representing a revenue increase of $820,729 or 91%.  The net gain in revenue was attributed to an increase in MedClean System sales of  $1,010,200, and a decrease of $(189,472) in the sale of consumables, component parts, and service contracts.

Revenues from MedClean System Sales for 2011 were $1,010,200 compared to $-0- in 2010

Revenues derived from the sale of consumables, component parts and service contracts decreased to $707,521 compared to $896,993 in the prior year. The revenue was attributable to orders for goods and services from the Company’s existing installed base of hospitals that have previously purchased a MedClean System. Service revenues decline in direct proportion to a reduction in corrective maintenance services work. Service billings will continue to fluctuate period to period based upon equipment service requirements.

The gross profit for 2011 was $725,752 (42.3% of total revenue) compared with a gross profit in 2010 of $470,295 (52.5% of total revenue). The decrease in gross profit margin as compared to the prior year can be attributed to lower profit margins on system sales. The components of costs of revenues for system sales include direct materials, depreciation, shipping and rigging costs, and contract labor.

Total operating expenses for 2011 were $3,579,315 compared with $4,787,192 for 2010, a decrease of $1,207,877 or 25.3%. In 2011, the Company incurred a $1,204,799 non-cash charge to operations for the fair value of vesting options and warrants as compared to $2,060,985 in 2010 and $0 in 2011 for stock based compensation as compared to $227,640 in 2010; a net decrease of $1,083,826, while other operating costs were reduced by $124,051 in 2011 versus 2010.

Net loss for 2011 was $(4,376,105) compared to a net loss in 2010 of $(4,417,550).

The Company has filed its Form 10-K for the year ended December 31, 2011 with the Securities and Exchange Commission, and investors are encouraged to visit www.sec.gov to review this document, which includes financial tables and additional detail for the year ended December 31, 2011.

Financial Results Conference Call

MedClean will host a conference call that will be broadcast live over the Internet on Monday, May 21, 2012 at 1:30pm ET to discuss the Company's 2011 financial results. Investors can access the call at http://public.viavid.com/index.php?id=100578. To listen to the live call via the telephone, please call 1-877-941-1427. For calls from outside North America, please dial 1-480-629-9664.  For those who cannot listen to the live broadcast, a replay will be available shortly after the call by dialing 1-877-870-5176 within North America, or 1-858-384-5517 from outside North America. The replay will be available until 11:59 p.m. ET. Reference replay pin number: 4540462.

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethlehem, Pennsylvania. Further information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business; including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2010, filed with the SEC on March 31, 2011, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Contact:

Cameron Donahue

Hayden IR

(651) 653-1854

Exclusive Program Includes Medical Waste Brokerage Services, Hauling Services, and Billing and Administrative Support Services to more than 100,000 Non-Acute Care GPO Member Facilities

BETHLEHEM, Penna., April 10 /PRNewswire-FirstCall/ — MedClean Technologies (OTC Bulletin Board: MCLN), the leading provider of technology designed for the efficient treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced it has partnered with MedPro Waste Disposal LLC and the Independent Medical Waste Transporters Association (IMWTA) to implement their first initiative to organize and utilize the IMWTA members extensive services.

The Medical Waste Hauling Program is sponsored by MedClean and powered by MedPro’s dedicated account management and sales teams.

Highlights of the program include, but are not limited to:

·       Exclusive relationship with a major U.S. based Group Purchasing Organization and their member base of more than 100,000 non-acute care facilities

o   Exclusivity spans a minimum period of 24 months

·       Guaranteed customer savings of 20% or more based upon the term of the agreement

·       “No Surprise” billing services.  All costs of the program are disclosed at the time the Service Agreement is signed and remain fixed for the duration of the Service Agreement

·       Utilization of MedPro’s dedicated team for the implementation of the program to ensure the program is offered to all members.  The campaign includes telemarketing, bid/proposal management to the IMWTA, contract administration, and customer billing services

·       Utilization of IMWTA members hauling services to provide local, friendly, and high quality services

·       Targeted market represents 10% to 20% of the $3.5 billion dollar medical waste market

“This is a landmark program for the Regulated Medical Waste industry, specifically to the small quantity waste generator (SQG), which typically pays significantly higher prices for hauling services due to the fact that only one entity existed in the market place that had the bandwidth to serve the market,” commented David Laky, President and CEO, MedClean Technologies, Inc.  “Through the partnerships we have developed, we have been able to identify a target market, develop a savings program for that market, increase the value proposition our GPO partner provides to that market, and most importantly deploy high quality services to the participants. Our partners are committed to the success of this program and have backed that commitment through contracted milestones. Additional goals of the program include enhanced opportunity for ecommerce sales and through tracking waste volumes handled by the IMWTA we will be able to pinpoint key opportunities to place localized medical waste processing centers featuring our MedClean Series equipment.”

About MedPro Disposal LLC

MedPro Waste Disposal LLC (MedPro) provides reliable, cost-effective medical waste disposal services to large and small quantity generators of medical waste. At, MedPro, we recognized a need for standardized costs across an industry largely dominated by a single entity. There were too many instances where customers were being charged drastically different prices for the same service. Some industry leaders continue to use this pricing strategy on their own customers, charging similar waste generators not-so-similar prices. In an industry full of regulations, there appeared to be none when it came to reasonable and fair business practices.

MedPro has formed an alliance with MedClean and the IMWTA transporters to provide the safest and most economical destruction of medical waste. Our goal is to ensure that our customers receive the quick, reliable service you have come to expect from your medical waste hauler with the peace of mind that you are not paying more than your neighbor, and that your waste is being properly disposed of.

Visit MedPro Waste Disposal LLC at http://www.medprodisposal.com

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable healthcare providers and medical waste haulers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities now located in Bethlehem, Pennsylvania. Additional information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2010, filed with the SEC on March 31, 2011, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Community Medical Center Installation

If you are interested in a MedClean System or MedClean's Waste Hauling brokerage services please click here to request additional information.

MedClean Technologies Signs Contract for Installation of MedClean System at Community Medical Center in Scranton, PA.

Signing is in conjunction with ARAMARK implementing hospital management and expense reduction programs.

BETHLEHEM, PA, November 17, 2011, /PRNewswire-FirstCall/ — MedClean Technologies (OTC Bulletin Board: MCLN), the leading provider of onsite technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced it has signed an agreement with ARAMARK for the purchase of a MedClean 4300 fixed-based sterilization system.

The agreement includes the purchase and installation of the equipment at Community Medical Center in Scranton, PA, plus additional recurring consumable orders for the life of the equipment, estimated for a period of approximately 10 years.  ARAMARK will provide comprehensive hospital management services that include implementing expense reduction programs that incorporate the use of MedClean’s sterilization technology.  The installation of the equipment is expected to commence and be completed in the fourth quarter of 2011.

“This agreement represents a case study in cooperation amongst ARAMARK, Community Medical Center, and MedClean to achieve beneficial results in the form of expense reductions utilizing MedClean’s fixed-base technology, ARAMARK’s industry leading hospital service capabilities, and Community Medical Center’s own personnel,” commented David Laky, President and CEO of MedClean Technologies, Inc. “We appreciate the fact the we were able to work in partnership with ARAMARK on this project and we will strive to continue to offer beneficial programs to ARAMARK and their valued customers.”

“The deployment of the MedClean 4300 system will enable ARAMARK to reduce its operating costs while continuing to serve the Community Medical Center,” continued Mr. Laky. “Cost effective services and solutions are critical to all organizations in the current economy.”

About ARAMARK

ARAMARK is a leader in professional services, providing award-winning food services, facilities management, and uniform and career apparel to health care institutions, universities and school districts, stadiums and arenas, and businesses around the world. The company is recognized as one of the "World's Most Ethical Companies" by the Ethisphere Institute, as the industry leader in FORTUNE magazine's "World's Most Admired Companies," and as one of America's Largest Private Companies by both FORTUNE and Forbes magazines. ARAMARK seeks to responsibly address issues that matter to its clients, customers, employees and communities by focusing on employee advocacy, environmental stewardship, health and wellness, and community involvement. Headquartered in Philadelphia, ARAMARK has approximately 255,000 employees serving clients in 22 countries. Learn more at www.twitter.com/aramarknews.

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further, information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 3, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Company Increases Revenue 96.5% versus 3^rd Quarter 2010.  Revenue Year-to-Date exceeds total revenue for all of 2010.

BETHLEHEM, PA., November 14, 2011 /PRNewswire-FirstCall/ — MedClean Technologies, Inc. (OTC Bulletin Board: MCLN) today announced financial results for the 2011 third quarter for the period ended September 30, 2011.

Some recent highlights include:

The company has dramatically improved its operating structure over the last two years, with improvements to the following key metrics, representing tangible progress:

·         Focus on recurring revenue opportunities will start to add to consistent minimum revenue reported on a quarterly basis:

o   MedClean is averaging $62,000 per quarter in contract maintenance. Any new systems sales going forward will increase this figure incrementally, typically adding $7,500k per quarter per sale.

o   For corrective maintenance, MedClean has averaged $74,000 per quarter over the past eight quarters. This number will fluctuate quarterly, but management expects the amount to remain close to its running average per quarter going forward.

o   MedClean’s new ecommerce line of business (MedClean GPO), which was launched in the third quarter, generated $24,000 for the third quarter. Management expects this to ramp to a quarterly run rate of approximately $60,000 starting in Q1 2012. Additional upside is attainable as the current annual market for disposal sharps alone is $280 million and the Company will also be selling other mainstream consumable products such as red bags, autoclave bags, boxes, etc., that comprise an even greater annual market spend.

o   Consumables for MedClean Systems (cart liners, deodorizer, supplies, etc.,) are at a run rate of $34,500K per quarter and incremental system sales add approximately $3,000 to $5,000 per quarter.

o   In aggregate, MedClean is now at a quarterly revenue run rate of $194,500K and starting in Q1 2012, management expects to average approximately $250,000 per quarter for annual revenue (including the expected increase in ecommerce products and revenue associated with new sales plus revenue generated from the sale of consumables to our processing center/distributor partners). This equates to recurring revenue totaling $1.0 million, which is $103,000 greater than our total revenue reported for all of 2010.

o   The profit margin for MedClean’s recurring revenue streams is generally around 50%.

o   The current expected cash burn run rate is approximately $1.6 million annually. The cash burn run rate has decreased by 34% percent, or $77,000, per month compared to 2009 when the new management team took over and is currently 12% lower than one year ago. Major contributing factors include a 75% reduction in corporate headquarter expense, a reduction in lease payments from $21,000 per month in 2009 to $5,500 currently; a 44% decrease in wages and salaries through the first nine months of 2011 to $1.67 million compared to $2.3 million for the same period one year ago; and a reduction in third-party consulting services of $24,000 per month.  (The Company recently completed its relocation from Bethel, CT to Bethlehem, PA).

o   With the expected revenue of $1.0 million in consumable and maintenance revenue for 2012 at 50% margin, management expects gross profit from this division to be $500,000.  At the current cash burn rate of $1.6 million annually that leaves $1.1 million in annual cash burn before MedClean System sales and installations.

o   Through the first nine months of 2011, MedClean has sold and installed three systems.  By continuing on the same pace in 2012 the Company could achieve positive cash flow by selling and installing (or installing potions of backlog) four systems at an average price of $750,000, using current system sales margin of 35%

o   MedClean currently has nine deals in advanced stages in its pipeline that have been quoted and proposed at or above our target pricing level.  Management is currently negotiating specific project details on several installations for items in its backlog.  Of the nine deals, seven have been generated by MedClean’s distribution partners.

“The run rate for our current business, not including the incremental maintenance and consumable revenue from any additional system sales or further increases from our newly launched MedClean GPO business line, demonstrates that we have made significant strides in creating a self-sustaining, cash generating business model,” stated David Laky, President & CEO of MedClean Technologies, Inc. “The transformation of our business has taken longer than we initially expected, due in large part to the state of the business we inherited, but our efforts have culminated in the creation of a sustainable business model.  The expansion of our service offerings into an integrated waste stream service provider adds more opportunity for recurring service revenues and will continue to reduce our dependency on one time sales. As we further prove out our operating results and show the leverage we have developed within our operational model, we believe the market will respond in a positive manner.”

In addition to the operational update the Company has indicated above based on tangible results, there are also several other opportunities Management has positioned the company to take advantage of:

·         Develop “localized” waste processing center facilities at stand-alone locations, utilizing contracts with multiple nearby medical waste producers

o   MedClean is currently working with several partners to move forward on this venture and expect to finance the facilities in a joint venture structure utilizing a debt structure that will be based at the plant level.

o   Management’s initial goal has been to establish the operational model and infrastructure required to enable the Company to expand into a service and recurring revenue model. Expansion into the “localized” waste processing center model will leverage the Company’s new operational model and current infrastructure and will not impact  or extend the time it will take to achieve cash flow positive status.

o   Management has identified two partners at two separate locations where permitting and long-term waste contracts with surrounding medical facilities have conditionally been approved and would be utilized pending financial approval.

o   The Company expects to generate approximately $500,000 per year in revenue per facility based upon preliminary contract discussions with the surrounding waste generators and partners.

o   There are five to six additional locations that have been identified as potential follow-on locations with the model being repeatable in virtually any metropolitan area across the U.S. (the model requires only several millions of pounds of waste to be profitable).

Mr. Laky added, “Based on the business overview we have provided here today, and the progress we expect to achieve in the next few months, we anticipate conducting a conference call in conjunction with our fourth quarter and year-end financial disclosure. This call, which is expected to include a question and answer session for shareholders, is expected to be sometime in late March, pending timing of our year-end audit. We feel this will provide the best forum to provide additional color on our progress as over the past six months we have been predominantly focused on operations of the company.”

Third Quarter Financial Results:

Total revenue for the quarter ended September 30, 2011 was $602,947 compared with $306,825 for the same period in 2010, an increase of  $296,121 million, or 96.5%.  In 2011 the Company was able to deliver systems completing contractual obligations and meeting revenue recognition policies totaling $445,200 versus $0 for the period in 2010.  Revenues derived from the sale of consumables, component parts, service billings, and amortization of maintenance contracts decreased by $149,079 or 48.6% in the current quarter to $157,146.  The decrease in service billings was a result of fewer service calls required due to equipment issues. Service billings will continue to fluctuate period to period based upon equipment service requirements.

Gross profit on system revenue during the three months ended September 30, 2011, was $156,443 compared to $0 for the same period in 2010. Gross profit on the sale of consumables, component parts, service billings and amortization of maintenance contracts during the three months ended September 30, 2011, was $91,608 compared to $253,741 for the same period in 2010.

Net loss for the three month period ended September 30, 2011, was $648,746, compared to a loss of $750,158 for the same period in 2010.

Year-To-Date Financial Results:

Total revenue for the nine months ended September 30, 2011, was $1,387,127, compared with $707,450 for the same period in 2010, an increase of $679,677 or 96.1%. System revenue during the nine month ended September 30, 2011, was $895,200, compared to $0 in 2010. The increase in system revenue was the result of the completion of the Company’s first containerized system and the installation of a fixed based system. Revenues derived from the sale of consumables, component parts, service billings and amortization of maintenance contracts decreased by $215,523 or 30.5% in the current period to $491,927. The decrease in service billings was a result of fewer service calls required due to equipment failure. Service billings will continue to fluctuate from period to period based upon equipment failure, whether through operator error or wear and tear, and pre-scheduled service activities such as equipment relocation. Service revenue attributable to contract revenues is recognized at the time of performance and not at the time of contract execution.

The Company has filed its Form 10-Q for the period ended September 30, 2011 with the Securities and Exchange Commission, and investors are encouraged to visit www.sec.gov to review this document, which includes financial tables and additional detail for the quarter ended September 30, 2011.

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethlehem, Pennsylvania. Further information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business; including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2010, filed with the SEC on March 31, 2011, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Contact:

Cameron Donahue

Hayden IR

(651) 653-1854

Enhances Triumvirate Environmental Services to Include Integrated Medical Waste Disposal Services to Complement Environmental Waste Services already Provided to Current Customer Base

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean’s flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further, information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are “forward-looking statements” within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words “may,” “will,” “should,” “anticipate,” “believe,” “appear,” “intend,” “plan,” “expect,” “estimate,” “approximate,” “potential” and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2010, filed with the SEC on March 31, 2011, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Important information regarding MedClean Technologies and our go forward strategy.

Kind Regards,

MedClean

Perfect Fit! ~ The 1st Picture of Barnett Medical Services MedClean System Treatment Facility

The MedClean System Container offers so many unique benefits from the obvious portability to the self-containment and small footprint.  It is truly a unique opportunity for independent medical waste transporters to take advantage of if considering building their own medical waste treatment facility or expanding from their current space.  It also offers unique benefit to hospitals, disaster relief situations, and to those considering joint venture processing facilities with the use of The MedClean Container System. 

Stay tuned for more container photos.

Kind Regards,

MedClean   

With this relationship, Covidien’s national sales force for SharpSafety products will promote MedClean products and services in a complimentary manner to MedClean’s existing Distributor sales force. As a result of this relationship with Covidien, and the MedAssets relationships already in place, MedClean will have multiple sales professionals promoting the Company in nearly every hospital in the U.S. In addition, MedClean will sell and distribute Covidien’s market-leading sharps and waste containers.

“This relationship is our largest co-promotion arrangement to date, broadening the exposure of our products and connecting MedClean with nearly every hospital in the country,” commented David Laky, MedClean’s President and CEO.  “One of the goals of this co- promotion relationship is to ensure the market is educated about disposable sharps versus reusable sharps and the benefits, through safety and expense reduction, that disposable sharps programs provide to healthcare facilities. We estimate the market for sharps containers to exceed $280million annually, and capturing a significant share of this market is a priority for both companies. We are excited to collaborate with Covidien and look forward to a long and mutually productive relationship.”

MedClean now has approximately 98 sales professionals in 50 states plus Canada promoting the Company’s innovative Technology enabled Solutions (TeS) for the treatment and disposal of medical waste and the destruction of confidential documents and related media.

“The extended sales cycle and the process for educating sales professionals on the benefits and details of our systems takes about six to nine months,” added Mr. Laky. “We continue to see distributors ramping up their lead generation efforts over this time frame, and as such we believe we will see an acceleration of our sales in the coming quarters due to the many relationships we have brought on board in the last year.”

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business; including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 3, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

We look forward to posting more information regarding the IMWTA Event being held next Tuesday in Dallas, TX at the Waste Expo.

Kind Regards,

MedClean